This company has been acquired
Radius Health Management
Management criteria checks 2/4
Key information
G. Martin
Chief executive officer
US$3.5m
Total compensation
| CEO salary percentage | 17.17% |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
Radius Recycling's Surge Justifies A Reevaluation
Mar 14Radius Recycling Will Benefit From Steel Tariffs
Feb 25Radius Recycling Stays In The Scrap Pile
Jul 16Radius Recycling: An Attractive, But Volatile, Play On A Cleaner Future
Jun 03Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype
Aug 11Reevaluating Radius Health
Feb 24When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?
Feb 23
How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 01
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$69m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$600k | -US$70m |
| Sep 30 2021 | n/a | n/a | -US$76m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$87m |
| Dec 31 2020 | US$12m | US$413k | -US$109m |
Compensation vs Market: G.'s total compensation ($USD3.49M) is above average for companies of similar size in the US market ($USD2.61M).
Compensation vs Earnings: G.'s compensation has been consistent with company performance over the past year.
CEO
G. Martin (63 yo)
Mr. G. Kelly Martin has been Executive Chairman of Wren Therapeutics Ltd. since 2018. Mr. Martin serves as the Chief Executive Officer, President and Director at Radius Health, Inc. since April 28, 2020.H...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$3.49m | no data | |
| VP of Sales & Head of U.S. Sales Channels | less than a year | US$741.78k | no data | |
| Senior VP & Chief Business Officer | 2.2yrs | US$1.22m | 0.27% $ 1.3m | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| VP, CFO | less than a year | no data | no data | |
| Head of Corporate Finance | no data | no data | no data | |
| Head of Investor Relations | less than a year | no data | no data | |
| General Counsel | less than a year | no data | no data | |
| Head of Corporate & Business Development | less than a year | no data | no data |
Experienced Management: RDUS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$3.49m | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.7yrs | US$544.81k | 0.045% $ 215.1k | |
| Independent Director | 2yrs | US$534.84k | 0.012% $ 55.5k | |
| Independent Director | 7.8yrs | US$536.69k | 0.037% $ 178.7k | |
| Chairman of Scientific Advisory Board | 10.5yrs | US$30.00k | no data | |
| Independent Chairman | 9.3yrs | US$832.23k | 0.034% $ 163.1k | |
| Independent Director | 7yrs | US$556.41k | 0.045% $ 215.1k | |
| Member of Scientific Advisory Board | 3.8yrs | US$1.94m | no data |
Experienced Board: RDUS's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/11 03:56 |
| End of Day Share Price | 2022/08/11 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Radius Health, Inc. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gregory Harrison | BofA Global Research |
| John Newman | Canaccord Genuity |
| Mara Goldstein | Cantor Fitzgerald & Co. |